🔗 Share this article

Texas Attorney General Paxton is taking legal action against the makers of Tylenol, alleging the companies hid safety concerns that the drug presented to children's neurological development.

The court filing follows four weeks after Donald Trump publicized an unsubstantiated connection between consuming Tylenol - also known as paracetamol - while pregnant and autism in young ones.

The attorney general is filing suit against J&J, which once produced the drug, the exclusive pain medication approved for women during pregnancy, and Kenvue, which presently makes it.

In a statement, he stated they "misled consumers by profiting off of suffering and pushing pills without regard for the dangers."

The manufacturer asserts there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, deliberately risking numerous people to boost earnings," the attorney general, a Republican, said.

The company commented that it was "seriously troubled by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its official site, the company also stated it had "continuously evaluated the applicable studies and there is no credible data that indicates a proven link between consuming acetaminophen and autism spectrum disorder."

Organizations speaking for medical professionals and health professionals share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in Tylenol - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can create serious health risks if left untreated.

"In over twenty years of research on the utilization of paracetamol in gestation, no reliable research has conclusively proven that the usage of paracetamol in any stage of gestation results in brain development issues in young ones," the association said.

The lawsuit references recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

Last month, Trump raised alarms from public health officials when he told pregnant women to "struggle intensely" not to use Tylenol when sick.

Federal regulators then published an announcement that doctors should consider limiting the use of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in minors has not been established.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to conduct "comprehensive study program" that would identify the source of autism spectrum disorder in a limited time.

But authorities advised that identifying a sole reason of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a type of permanent neurological difference and disability that affects how persons perceive and interact with the surroundings, and is recognized using medical professional evaluations.

In his court filing, Paxton - a Trump ally who is seeking federal office - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the companies "destroy any commercial messaging" that states acetaminophen is reliable for expectant mothers.

The court case parallels the grievances of a collection of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in recently.

A federal judge rejected the case, stating studies from the family's specialists was inconclusive.